COVID19

MEDI:GATE NEWS Celltrion applies for conditional approval from the Ministry of Food and Drug Safety for COVID-19 treatment and initiates global approval process

Celltrion completes Phase 2 clinical trial for COVID-19 antibody treatment

WHO “In order to cope with COVID-19 mutations, genome sequencing must be increased and shared”: Dong-A Science

Celltrion applies for conditional approval of COVID-19 treatment this week… “Permission decision in early February”

[속보] Authorities “confirmed COVID-19 mutant virus in arrivals from UK”

[현장생중계]High-ranking parties, governments, and governments announce the results of the 3rd COVID-19 disaster support fund discussion

Variant COVID-19 spread across Europe and Asia to Canada

Discussing whether to vaccinate the KATUSA Soldier Covid-19 vaccine assigned to the USFK

[사회]1,132 new patients with COVID-19 … report of mutant virus outbreak in South Africa

5 Japanese and 1 Lebanon confirmed cases of COVID-19 strain from the UK

Daewoong Pharmaceutical’s’Hoy Star’ confirmed the possibility of treating COVID-19

Wearing a mask without distance, insufficient prevention of COVID19 Science Monitor